冠状动脉疾病中的基因调控网络
Jenny Cheng1,2, Michael Cheng1,3, Aldons J Lusis4,5
1Department of Integrative Biology and Physiology, University of California, Los Angeles, 610 Charles E. Young Drive East, Los Angeles, CA, 90095, USA.
Current atherosclerosis reports
|November 26, 2023
概括
基因调节网络为冠状动脉疾病 (CAD) 机制提供了强大的洞察力. 本综述强调了用于CAD中基因调节建模的先进工具和数据库,有助于理解疾病遗传性和关键驱动因素.
科学领域:
- 基因组学和系统生物学
- 心血管研究研究心血管研究
背景情况:
- 冠状动脉疾病 (CAD) 是全球主要的健康问题,也是导致死亡的主要原因.
- 高通量多态数据生成已经进步,使复杂的生物网络分析成为可能.
- 基因调控网络 (GRN) 建模正在成为理解复杂疾病 (如CAD) 的关键工具.
研究的目的:
- 审查用于CAD研究的批量和单细胞数据的最新和新型GRN工具.
- 识别和讨论现有数据库对于构建基因调节网络至关重要.
- 总结GRNs在解开冠状动脉疾病机制和遗传性的多样化应用.
主要方法:
- 讨论构建基因调节网络的算法方法.
- 强调用于建模特定基因调节模式的最先进方法.
- 使用冠状动脉疾病患者数据库探索GRN应用程序.
主要成果:
- 新的GRN工具整合了多组学数据,以高分辨率阐明复杂的疾病机制.
- 更新的CAD表达数据有助于GRN的构建,以发现新的机制.
- GRN有效地解释了超出GWAS位点的CAD遗传性,并确定了关键疾病驱动基因.
结论:
- 基因调节网络为了解冠状动脉疾病的复杂性提供了一个整体的方法.
- 基因基因基因在识别跨组织,性别和物种共享和独特的疾病机制方面发挥着重要作用.
- 先进的GRN工具和数据库正在加速心血管疾病研究中的发现.
更多相关视频
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Pathophysiology of Cardiac Performance
674
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
674
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
533
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
533
Regulation of Heart Rates
1.8K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.8K


